ALLO Institutional Ownership & Shareholders
ALLOGENE THERAPEUTICS INC (ALLO) is currently held by 203 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $646.50M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is currently the largest disclosed institutional shareholder of ALLO tracked by InsiderSet, reporting ownership valued at approximately $62.71M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $35.87M, representing an estimated loss of -42.79% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 56% of the total disclosed ALLO value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Pfizer Inc, Frazier Life Sciences Management, L.P., and several other long-term asset managers with concentrated positions in ALLOGENE THERAPEUTICS INC (ALLO).
This page ranks the largest institutional ALLO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
203
Total Reported Value
$646.50M
Largest Holder
Blackrock, Inc.
Largest Position
$62.71M
Insider Transactions (90d)
2
Latest Filing Quarter
Q2 2026
New Institutional Positions
71
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Blackrock, Inc. | 0.00% | 30,146,963 | $62,705,681 | $35,874,886 | -$26,830,795 | -42.79% | |
| Pfizer Inc | 27.55% | 22,032,040 | $46,928,245 | $26,218,128 | -$20,710,117 | -44.13% | |
| Frazier Life Sciences Management, L.P. | 1.02% | 22,446,668 | $46,689,069 | $26,711,535 | -$19,977,534 | -42.79% | |
| State Street Corp | 0.00% | 19,025,826 | $39,573,718 | $22,640,733 | -$16,932,985 | -42.79% | |
| Tpg Gp A, Llc | 0.78% | 18,716,306 | $38,929,916 | $22,272,404 | -$16,657,512 | -42.79% | |
| Sio Capital Management, Llc | 4.75% | 13,323,431 | $27,712,736 | $15,854,883 | -$11,857,853 | -42.79% | |
| Primecap Management Co/Ca/ | 0.02% | 13,123,440 | $27,296,756 | $15,616,894 | -$11,679,862 | -42.79% | |
| Vanguard Capital Management Llc | 0.00% | 12,166,636 | $25,306,603 | $14,478,297 | -$10,828,306 | -42.79% | |
| Fmr Llc | 0.00% | 12,009,043 | $24,978,809 | $14,290,761 | -$10,688,048 | -42.79% | |
| Citadel Advisors Llc | 0.01% | 10,087,770 | $20,982,562 | $12,004,446 | -$8,978,116 | -42.79% | |
| Two Sigma Investments, Lp | 0.01% | 7,784,348 | $16,191,444 | $9,263,374 | -$6,928,070 | -42.79% | |
| Geode Capital Management, Llc | 0.00% | 7,049,328 | $14,666,040 | $8,388,700 | -$6,277,340 | -42.80% | |
| Goldman Sachs Group Inc | 0.00% | 6,148,959 | $12,789,834 | $7,317,261 | -$5,472,573 | -42.79% | |
| Gordonmd Global Investments Lp | 5.33% | 5,298,000 | $11,019,840 | $6,304,620 | -$4,715,220 | -42.79% | |
| Marshall Wace, Llp | 0.01% | 5,095,408 | $10,598,449 | $6,063,536 | -$4,534,913 | -42.79% | |
| Patient Square Capital Lp | 1.63% | 5,050,000 | $10,504,000 | $6,009,500 | -$4,494,500 | -42.79% | |
| Aberdeen Group Plc | 0.01% | 5,001,752 | $10,403,644 | $5,952,085 | -$4,451,559 | -42.79% | |
| Millennium Management Llc | 0.01% | 4,843,889 | $10,075,289 | $5,764,228 | -$4,311,061 | -42.79% | |
| D. E. Shaw & Co., Inc. | 0.01% | 4,710,735 | $9,798,329 | $5,605,775 | -$4,192,554 | -42.79% | |
| Price T Rowe Associates Inc | 0.00% | 4,639,283 | $9,651,000 | $5,520,747 | -$4,130,253 | -42.80% | |
| Morgan Stanley | 0.00% | 4,509,962 | $9,380,720 | $5,366,855 | -$4,013,865 | -42.79% | |
| Woodline Partners Lp | 0.03% | 4,500,624 | $9,361,298 | $5,355,743 | -$4,005,555 | -42.79% | |
| Vanguard Portfolio Management Llc | 0.00% | 4,212,078 | $8,761,122 | $5,012,373 | -$3,748,749 | -42.79% | |
| Candriam S.C.A. | 0.04% | 5,422,820 | $8,708,213 | $6,453,156 | -$2,255,057 | -25.90% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 3,834,312 | $7,975,369 | $4,562,831 | -$3,412,538 | -42.79% |
| Hrt Financial Lp | 0.01% | 3,621,579 | $7,532,000 | $4,309,679 | -$3,222,321 | -42.78% | |
| Walleye Capital Llc | 0.03% | 3,268,012 | $6,797,465 | $3,888,934 | -$2,908,531 | -42.79% | |
| Rtw Investments, Lp | 0.06% | 3,250,000 | $6,760,000 | $3,867,500 | -$2,892,500 | -42.79% | |
| Bank Of America Corp | 0.00% | 3,187,320 | $6,629,626 | $3,792,911 | -$2,836,715 | -42.79% | |
| Ubs Group Ag | 0.00% | 3,038,392 | $6,319,855 | $3,615,686 | -$2,704,169 | -42.79% | |
| Ghisallo Capital Management Llc | 0.12% | 3,000,000 | $6,240,000 | $3,570,000 | -$2,670,000 | -42.79% | |
| Northern Trust Corp | 0.00% | 2,955,282 | $6,146,986 | $3,516,786 | -$2,630,200 | -42.79% | |
| Dimensional Fund Advisors Lp | 0.00% | 3,202,488 | $5,124,399 | $3,810,961 | -$1,313,438 | -25.63% | |
| Charles Schwab Investment Management Inc | 0.00% | 2,274,363 | $4,730,675 | $2,706,492 | -$2,024,183 | -42.79% | |
| Wildcat Capital Management, Llc | 2.68% | 2,920,787 | $4,673,259 | $3,475,737 | -$1,197,522 | -25.62% | |
| Aqr Capital Management Llc | 0.00% | 2,006,288 | $4,173,079 | $2,387,483 | -$1,785,596 | -42.79% | |
| Dafna Capital Management Llc | 0.79% | 2,000,000 | $4,160,000 | $2,380,000 | -$1,780,000 | -42.79% | |
| Vanguard Fiduciary Trust Co | 0.00% | 1,838,344 | $3,823,756 | $2,187,629 | -$1,636,127 | -42.79% | |
| Jpmorgan Chase & Co | 0.00% | 1,438,434 | $3,193,323 | $1,711,736 | -$1,481,587 | -46.40% | |
| Boxer Capital Management, Llc | 0.23% | 1,500,000 | $3,120,000 | $1,785,000 | -$1,335,000 | -42.79% | |
| Jacobs Levy Equity Management, Inc | 0.01% | 1,455,103 | $3,026,614 | $1,731,573 | -$1,295,041 | -42.79% | |
| Raiffeisen Bank International Ag | 0.02% | 1,100,000 | $1,782,000 | $1,309,000 | -$473,000 | -26.54% | |
| Hennion & Walsh Asset Management, Inc. | 0.05% | 1,039,328 | $1,662,925 | $1,236,800 | -$426,125 | -25.63% | |
| Invesco Ltd. | 0.00% | 772,786 | $1,607,395 | $919,615 | -$687,780 | -42.79% | |
| Bank Of New York Mellon Corp | 0.00% | 727,182 | $1,512,540 | $865,347 | -$647,193 | -42.79% | |
| Man Group Plc | 0.00% | 701,901 | $1,459,954 | $835,262 | -$624,692 | -42.79% | |
| Raymond James Financial Inc | 0.00% | 678,972 | $1,412,262 | $807,977 | -$604,285 | -42.79% | |
| Nuveen, Llc | 0.00% | 624,648 | $1,299,268 | $743,331 | -$555,937 | -42.79% | |
| Ieq Capital, Llc | 0.01% | 580,371 | $1,207,172 | $690,641 | -$516,531 | -42.79% | |
| Mitsubishi Ufj Asset Management Co., Ltd. | 0.00% | 547,189 | $1,138,153 | $651,155 | -$486,998 | -42.79% |
Frequently asked questions about ALLO
Who are the largest institutional holders of ALLO?
The largest institutional holders of ALLO reported in the latest SEC Form 13F filings include Blackrock, Inc., Pfizer Inc, Frazier Life Sciences Management, L.P., State Street Corp, and Tpg Gp A, Llc. InsiderSet ranks institutional holders by their latest reported ALLO position.
What is ALLO institutional ownership?
This page tracks ALLO positions reported by institutional investment managers through SEC Form 13F. ALLOGENE THERAPEUTICS INC (ALLO) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own ALLO?
InsiderSet currently tracks 203 institutional managers reporting ALLO holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of ALLO shareholders.
How much ALLO stock do institutions own?
Institutional investment managers disclosed approximately $646.50M in ALLO holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was ALLO institutional ownership last updated?
The latest ALLO institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional ALLO holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its ALLO position after the reporting date.
Are institutions buying or selling ALLO?
Institutional buying and selling can be analyzed by comparing ALLO positions across consecutive 13F reporting periods. InsiderSet's ALLO Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View ALLO ownership changes.
How has ALLO institutional ownership changed over time?
InsiderSet tracks ALLO institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.